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A fully automated apparatus for the routine synthesis and
formulation of short-lived tiC (tt/2 20 min) labelled radio-
pharmaceuticals for positron emission tomography (PET) has
been developed. [tiC]Carbon dioxide is converted to [11C]methyl
iodide, which can be used to label a wide variety of substrates by
methylation at C, N, O, or S electron rich centres. The apparatus,
MIASA (methyl iodide automated synthesis apparatus), was
designed to operate as part of an automated labelling system in a
shielded’hot’ laboratory. The apparatus was designed without the
size constraints oftypical instrumentation used in hot cells, although
it is compact where necessary. Ample use of indicators and sensors,
together with compact design of the reaction flasksfor small dead
space and effcient evaporation, led to good reliability and
performance. The design of the hardware and software is described
in this paper, together with a preparation of 3-N-[11C]methyl-
spiperone as a sterile injectable solution in physiological saline.
Introduction
Positron emission tomography (PET) has developed into
a unique tool for obtaining quantitative physiological
images ofbiofunctions. A variety of applications are being
pursued--these are based on the fact that positron
emitters, such as 11C, 13N or 150, can be incorporated
into almost any biologically active tracer without altering
the chemical behaviour.
The labelling ofpharmaceuticals with the positron emitter
tC tbr use in PET studies is frequently accomplis.hed
using [tiC]methyl iodide as a labelling agent. Figure
shows the synthetic scheme used. The short half life of
11C (20"4 min) means it is essential to synthesize the
radiopharmaceuticals regularly and consistently on site.
It is usually necessary to start with relatively high levels
of radioactivity to obtain useful amounts of the required
products. So automation of the synthesis apparatuses, for
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example 3-6, within a radiation-shielded facility is
important for safe, reliable and efficient production of
radiopharmaceuticals for PET.
A number of remote controlled and semi- or fully
automated systems have been developed for labelling
[1-5-1. However, although these systems have begun to
address the need for producing labelled compounds, PET
has begun to move out of the research arena to become
a routine clinical tool and this is putting ever greater
demands on the automated apparatus. A reliable system
that can reproducibly deliver a variety of radiopharma-
ceuticals on a routine, repetitive basis would be desirable.
The commercial synthesis instruments on the market are
generally limited in their scope; need manual washing
before re-use; and/or require the attendance of specialist
operators or maintenance personnel.
A total system for routine production of PET radio-
pharmaceuticals is being developed at the Institute for
Biofunctional Research (IBR). This paper reports on the
design and construction of an apparatus for producing
radiopharmaceuticals by labelling with [ttC]methyl
iodidemMIASA (methyl iodide automated synthesis
apparatus)--and describes its application to synthesis of
3-N-[11C]methylspiperone as a sterile injectable solution
in physiological saline.
General features
Figure 2 shows the general layout of the facilities at IBR
which were designed for the development of a total
production system from the cyclotron to the PET camera.
The production of 11C is accomplished by the nuclear
reaction of cyclotron-accelerated protons with nitrogen
gas, 14N(p,z)tlC, in a target chamber. A Sumitomo
Heavy Industries HM-18 cyclotron is used for this. Pico
mole quantities of 11C undergo rapid oxidation to
[11C]carbon dioxide in the target chamber or by passage
over a CuO catalyst. Incorporation of the positron
emitters into the radiopharmaceuticals takes place in the
hot laboratory, which is designed to contain several fully
automated synthesis instruments under computer control.
Communication with a network of OPTOMUX (Opto
22, USA) modules allows flexible control and monitoring
of all devices [4, 6]. After quality assurance procedures
have been completed, the sterile product is passed through
to the PET camera room.
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1) THF, -20C
4(11CO2) + 3LiAIH4 LiAI(O11CH3)4 + 2LiAIO2
2) THF high temp
3) 4H20 low temp
4) Hl(aq) 11CH31 + H20 411CH3OH + LiOH + AI(OH)3
high ternp
sodalimep205 trap
11CH31
Figure 1. Schemefor the synthesis of [11C]methy iodide.
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Figure 2. Layout of the PET radiopharmaceutical production
laboratories.
Computer control system
Computer and interface hardware
The apparatus is controlled by a personal computer (NEC
9800 series) with standard monitor and printing peri-
pherals. The computer communicates with an OPTO-
MUX interface unit via a plug in RS422 adaptor card
and an interface board (FCB485, Asahi Electronics,
Japan). Six OPTOMUX digital and two analogue brain
boards, each with 16 I/O channels, are used. Five digital
output boards give 80 switches for operating valves and
relays, and one digital input board reads the status of 16
indicator lamps that are used for monitoring photosensors,
position and level sensors. The analogue boards are for
reading status information from the system, including
temperature, pressure, radioactivity, pH, UV absorbance,
and writing information to set temperature and gas flow
rates.
Computer software
The computer software for controlling the apparatus was
developed using a control software development tool
called ’Hyakuninriki’ (Asahi Electronics, Japan) operat-
ing under MS-DOS. The program consists of a series of
connected control blocks, with the flow depending on the
control logic sequence. More than 100 control blocks of
16 different types are used, and each block is programmed
to perform a function, such as controlling a switching
PSI1 PS4 "
[, P!6 ,
iver, _PS6,,]
s;art
signal
BN ;ep ,,__,N;I2 ;BN4
Figure 3. Control blocksfor HPLC injection: PS photosensor;
BN bit number.
sequence or reading the status of sensors. An example of
the layout of blocks and their connections for the control
of the HPLC injection procedure is shown in figure 3.
Figure 4 is a flowchart of the same procedure and a more
detailed explanation is given below for the injection
procedure during the synthesis of 3-N-[llC]methyl
spiperone.
The flowchart for checking the integrity of the apparatus,
the diagnostic check, is shown in figure 5. The status of
the apparatus is confirmed to be ready for synthesis by
intrachecking photosensors, micro-switch sensors, rotary
valve positions and performing leak tests, thus helping to
maintain reproducible and safe operation of the apparatus.
A typical program flowchart for a synthesis and formula-
tion procedure is shown in figure 6.
The synthesis apparatus
General
As the apparatus did not need to be operated in the
confines of a hot cell, it was possible to organize the
hardware for easy maintenance and for good reliability
and reproducibility. The reaction unit was kept compact
in order to minimize dead space in the two reaction
flasks (F1 and F2) and flow lines, which can lead to
dilution and losses of the 11C-labelling agents, but the
peripheral supply and service units were laid so that they
were easily accessible. The organization of the units on
the two racks (main and supply, 60 x 40 x 180 cm) is
shown in figure 7, and a schematic diagram of the
apparatus is shown in figure 8. The general appearance
ofthe apparatus and the reaction unit are shown in figures
9 and 10. Table lists the I/O connections of the MIASA
apparatus.
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6WV to Inject;
Auto zero UV;
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Figure 4. The HPLC injection procedure." 6WV six way rotary
valve," SP syringe pump," F2 reaction flask # 2.
//ind and correct/ /’ problem
rotary valves;
syringe pump
Check
photosensors
Diagnosis
OK?
/ind and correc
problem
Leak test 1) F1,
2) F2, 3)SLT/P205
trap, 4) F3 and 5) F4;
check mass flow
controller for zero flow
Figure 5. The diagnostic check sequence.
Layout the main rack
Electronics unit
Control boxes for the magnetic stirrers and pH meter
(NPH-10D, Nissin), 24V and 12V DC power supplies and
cable connectors are located on the top shelf of the main
rack. Temperature control ofthree reaction flasks (F1-F3)
is performed by three thermostat controllers (E5 series,
Omron), each with a variable voltage thyristor. Two of
the flasks, F1 (methyl iodide synthesis) and F3 (formula-
tion), use local control with a preset temperature value
and simple on/off capacity, but the temperature of flask
F2 (labelling) may freely be set remotely from the
computer during synthesis. This feature enables the
temperature to be set at a low value for trapping methyl
iodide and then increased for rapid labelling.
The control-boxes for a syringe-pump motor (SMPC-001,
Oriental Motor) and a liquid-level sensor on flask F4
(AL-66r, Nissin), and eight 37-pin cable connectors to the
I/O indicator-auto/manual switch box are also located
on this shelf.
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Start
Cool and flush F1
Start Collect
y Y
Collect 11 CO2
Evaporate
eluant in F3
Evaporate THF
in F1
HPLC
Dissolve in saline
AdjustpHinF4 il
/
Figure 6. Synthesis sequence (3-N-[ C]methylspiperone)
Reservoir supply unit
The reagents, reactants and solvents that are to be used
in the reaction flasks are stored in glass reservoirs, from
which they are dispensed as required. Figure 11 shows
the layout of the reservoir supply unit shelf.
The small volumes of liquids required, 100-200 gl from
reservoirs R1 and R4, are measured out using fixed-
position infra-red photosensors (EE-SX670, Omron) on
the Teflon tube delivery lines. A block of black PVC was
used to make a light shield which fits tightly into the well
of the photosensor; holes for the Teflon tubing (1"6 or
3"0 mm) and the light beam (1"0 mm ) cross in the
centre of the light path. The basic circuit for control of
dispensing from a reservoir is shown in figure 12. When
a reservoir is opened (Va and Vb on) and the photosensor
detects liquid, a signal is sent directly to the computer.
Simultaneously, in order to achieve good reproducibility,
the signal also switches a relay to immediately cut power
to the solenoid valve at the bottom of the reservoir (Vc).
A relay ($64) can switch off the operation of the
photosensors to allow washing.
Electronics Unit
Reservoir Unit
Reaction Unit
Purification Unit
Wash Unit
Interface Unit
I/O
Cooling Unit
Main Rack Supply Rack
Figure 7. Arrangement of the units on MIASA’s two racks.
Reaction unit
The front of this unit contains four flasks on four stirrers.
These are for:
(1) Synthesizing methyl iodide.
(2) Methylating the precursor compound.
(3) Collecting the separated product, evaporating eluant
and dissolving in saline solution.
(4) Adjusting the pH and final concentration.
Flask F1 has an outer jacket for cooling and an inner
jacket for heating. Coolant, fluorinert FC77, is circulated
from a cold bath and heating is performed with a nichrome
wire heater (c. 15 f) in silicone oil. The flask is designed
so that all the tubing connections to the inner reaction
vessel pass through the heating jacket; the flask is compact
which helps the efficient removal of solvent from the
connections during evaporation and drying processes.
Flask F2 has a single jacket containing fluorinert FC77,
which can be heated by a nichrome wire heater (c. 20
or cooled by circulation from the cold bath. The four
tubing connections pass through the jacket for compactness
and efficient drying of the flask. Flask F3 has a single
jacket filled with silicone oil, heated by a nichrome wire
(c. 20 ). The magnetic stirring bar is supported on a
Teflon disk on the Teflon tubing that dips down to the
bottom of the flask. The tube is made rigid by an outer
Teflon tube collar, so the stirrer bar spins freely. The
Teflon tubing passes through a Teflon-coated silicone disk
(septum) in the screw connector to minimize the dead
space in the flask top (this is difficult to dry during
evaporation). Flask F3 was also designed to minimize the
loss of product through bumping. A glass protuberance
is set just below the tubing connection to the vacuum line,
blocking the direct loss of solution to the drain. Flask F4
is fitted with a small pH electrode (CE105-C, Nissin) and
a level sensor to detect when the volume of the final
solution reaches a pre-set value, for example 10 ml.
The rear of the reaction unit houses solenoid valves and
a lead-shielded RI detector probe on the inlet line from
the [lC]carbon dioxide trap. A shelf above the reaction
flasks holds a stepping motor (2CSM-101, Oriental
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Figure 8. Schematic diagram of the [11C]MeI automated synthesis apparatus: (C) solenoid valves; C common; CP cooler pump;
MF massflow controller; NC normally closed; NO normally open; MP mobile phase;pH pH meter electrode; SP syringe
pump; RID radioisotope detector; UVD ultraviolet detector; VP vacuum pump; 6WV automated six-way injection valve.
Motor) for operating a syringe pump (25 ml)--this pushes
HPLC eluant from the injection loop to F2 and pulls the
reaction solution back into the injection loop.
To ensure the reliability of the injection procedure, two
photosensors are used for detecting the point when all the
reaction solution has gone into the sample loop. When
both photosensors go off, the sample is injected onto the
HPLC column by a motor-operated six-way micro rotary
valve (E010, Uniflows; 0"75 ml loop). Using two photo-
sensors means that if a small air bubble were to pass
through the Teflon tube, it would not accidentally cause
premature injection. A third photosensor is fitted to the
Teflon flow line just above F2 to detect when the push
of eluant fiom the sample loop should be stopped. The
set up shown in figure 13 was thus used to obtain
reproducible injection.
A manual six-way injection valve (7125, Rheodyne; 0"6 ml
loop), for calibration, and two manually operated six-way
selection valves (7060, Rheodyne) for changing the HPLC
flow line, and thus the HPLC column, are also located
on the same shelf. Five columns and one bypass line can
typically be connected.
When methyl iodide is passed from F1 to methylation
flask F2 it is necessary to remove traces of excess acid
(HI) and water by passing it through a trap containing
soda lime and P205. The trap is fitted to a motor-operated
six-way micro rotary valve (E010, Uniflows) to allow it
to be by-passed during the washing and drying procedure,
which can then follow immediately after synthesis. When
the bypass is a second, empty, trap, it can be cleaned and
made ready for use on the following run.
Purification unit
The two shelves below the reaction unit contain the
purification apparatus, consisting of a compact HPLC
pump (PU-980,Jasco) and UV detector (UV-970,Jasco),
and a radioisotope detector (positron detector, Aloka).
Figure 14 shows the layout of the unit.
Vacuum, wash and drainage unit
Also at the bottom of the main rack is a diaphragm type
vacuum pump, a.stainless-steel waste drain with a pressure
sensor to allow monitoring of the vacuum, three poly-
ethylene tanks for containing wash solvents and one tank
to collect solvents from the vacuum pump exhaust line.
An oil-type vacuum pump is used to obtain sufficient
suction for the evaporation in F3. A cooler, with a cold
trap, condenses vapour before it enters the pump.
Layout of the supply rack
OPTOMUX interface
The top halfof the supply rack contains the OPTOMUX
I/O interface which connects the apparatus to the
computer. The eight boards are housed in two boxes,
together with the necessary power supplies.
Digital I/O indicator and auto/manual switch box
A digital I/O box contains 80 indicator lamps/switches
for the five digital output boards and 16 indicator lamps
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Front View
4 5 6 7 8
Figure 9. General appearance of MIASA’s two racks.
Rear View
9 10 11 12 13
Figure 11. The Reservoir Supply Unit: 1 glass reservoir (acid
or base for pH adjustment); 2 silicon septum; 3 teflon
connector (5-3 mm ); 4 saline reservoir; 5-7 reservoirs
.for F2 reactants; 8 HI acid reservoir; 9-13 photosensors;
14 photosensor local control relay board.
Figure 10. MIASA’s reaction unit.
for the digital input board. One switch changes the
apparatus control from auto (computer) to manual
operation using the 80 switches. These switches simplify
maintenance.
Mass flow controllers
Argon and nitrogen gas flow rates are monitored and
regulated using mass flow controllers (O-500ml/min;
TO OPTOMUX N2 or Ar gas
oooT
-’.,.:
Va Vb Vc
Measure OFF ON ON
ON
Figure 12. Basic circuitfor dispensingfrom reservoirs. 1 reser-
voir; 2 photosensor; 3 24 V DC relay switching Vc off;
4 24 V DC relay switching 24 V power off; 5 24 V DC
power supply.
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Table 1. I/O connections of the MIASA apparatus.
Board Module Pin # Description Switch
Digital output (DOUT)
Address 00H
Address 01H
Digital output (DOUT)
Address 02H
Address 03H
ODC5
ODC5 2
ODC5 3
ODC5 4
ODC5 5
ODC5 6
ODC5 7
ODCS 8
ODC5 9
ODC5 10
ODC5 11
ODC5 12
ODC5 13
ODC5 14
ODC5 15
ODC5 16
ODC5 17
ODC5 18
ODC5 19
ODC5 20
ODC5 21
ODC5 22
ODC5 23
ODC5 24
ODC5 25
ODC5 26
ODC5 27
ODC5 28
ODC5 29
ODC5 3O
ODC5 31
ODC5 32
ODC5 33
ODC5 34
ODC5 35
ODC5 36
ODC5 37
ODC5 38
ODC5 39
ODC5 4O
ODC5 41
ODC5 42
ODC5 43
ODC5 44
ODC5 45
ODC5 46
ODC5 47
ODC5 48
ODC5 49
ODC5 50
ODC5 51
ODC5 52
ODC5 53
ODC5 54
ODC5 55
ODC5 56
ODC5 57
ODC5 58
ODC5 59
ODC5 60
ODC5 61
Not connected
Valve 2, connect N2 gas line to reservoir line
Valve 3, connect wash line to reservoir line
Valve 4, connect reservoir line to drain line
Valve 5, connect reservoir line to F1
Valve 6, connect syringe pump to F2
Valve 7, connect syringe pump to F4
Valve 8, connect reservoir line to drain
Valve 9, connect [1Ic]co2 inlet line to F1
Valve 10, connect reservoir line to F1
Valve 11, connect reservoir # to F1
Valve 12, connect reservoir #2 to F2
Valve 13, connect reservoir #3 to F2
Valve 14, connect reservoir #4 to F2
Valve 15, connect F1 to F2
Valve 16, connect HPLC line to F3
Valve 17, connect F3 to F4
Valve 18, connect reservoir # 5 to F3 or F4
Valve 19, connect reservoir #6 to F4
Valve 20, connect F4 to vial
Valve 21, connect F2 outlet to balloon
Valve 22, connect reservoir line to res #
Valve 23, connect reservoir line to F2
Valve 24, connect reservoir line to res # 2
Valve 25, connect reservoir line to F2
Valve 26, connect reservoir line to res # 3
Valve 27, connect reservoir line to F2
Valve 28, connect reservoir line to res #4
Valve 29, connect F2 to drain line
Valve 30, connect F3 to drain line
Valve 31, connect F4 to drain line
Valve 32, connect drain line to V4 and V36
Valve 33, connect drain line to vacuum pump
Valve 34, connect acetone tank to wash line
Valve 35, connect methanol tank to wash line
Valve 36, connect HPLC loop to drain line
Valve 37, connect reservoir # 5 to F4
Valve 38, connect reservoir line to res # 5
Valve 39, connect HPLC delivery line to F3
Valve 40, connect F1 to soda lime trap
Not connected
Valve 42, connect F4 to drain
Valve 43, connect reservoir line to F3
Relay 44, switch off HPLC pump
Valve 45, connectHPLC loop to F2 & s. pump
Relay 46, start HPLC pump
Relay 47, change position of 6WV" SLT/P205
Relay 48, change position of6WV: HPLC loop
Relay 49, switch heater # on
Relay 50, switch heater # 2 off
Relay 51, switch heater # 3 on
Relay 52, switch stirrer # off
Relay 53, switch stirrer # 2 off
Relay 54, switch stirrer # 3 off
Relay 55, switch stirrer #4 off
Relay 56, start syringe pump
Relay 57, set syringe pump to pull
Relay 58, set UV auto zero
Relay 59, switch diaphragm pump on
Relay 60, switch UV detector on
Relay 61, switch vacuum pump (oil) on
V1
V2
V3
V4
V5
V6
V7
V8
V9
V10
Vll
V12
V13
V14
V15
V16
V17
V18
V19
V20
V21
V22
V23
V24
V25
V26
V27
V28
V29
V30
V31
V32
V33
V34
V35
V36
V37
V38
V39
V40
V41
V42
V43
$44
V45
$46
V47
V48
$49
$50
S51
$52
$53
$54
$55
$56
$57
$58
$59
$60
S61
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Table 1 (continued)
Board Module Pin # Description Switch
Address 03H
Digital input (DIN)
Address 05H
Analogue input (AIN)
Address 06H
Analogue output (AOUT)
Address 07H
ODC5 62
ODC5 63
ODC5 64
IDC5 DIN1
IDC5 DIN2
IDC5 DIN3
IDC5 DIN4
IDC5 DIN5
IDC5 DIN6
IDC5 DIN7
IDC5 DIN8
IDCS DIN9
IDC5 DIN10
IDC5 DINll
IDC5 DIN12
IDC5 DIN13
IDC5 DIN14
IDC5 DIN15
IDC5 DIN16
AD6T AIN1
AD6T AIN2
AD6T AIN3
AD6T AIN4
AD6T AIN5
AD6T AIN6
AD9T AIN7
AD9T AIN8
AD9T AIN9
AD8T AIN 10
AD8T AIN 11
AD8T AIN 12
AD3T AIN13
AD3T AIN14
AIN15
AIN16
DA3T AOUT1
DA3T AOUT2
DA4T AOUT3
DA4T AOUT4
Relay 62, switch valve 62 on--coolant to F2
Relay 63, switch cooling pump on
Relay 64, switch photosensor power off
Photosensor # for reservoir #
Photosensor # 2 for reservoir # 2
Photosensor # 3 for reservoir # 3
Photosensor # 4 for reservoir # 4
Photosensor # 5 for reservoir # 5
Photosensor # 6 for HPLC injection
Level sensor on F4
Position of six-way valve for HPLC injection
Position of six-way valve for HPLC SLT/P205
Position of syringe pump
Photosensor # 11 above F2
Not connected
Not connected
Not connected
Not connected
Not connected
Not connected
pH meter (0-5 V)
Vacuum gauge (0-5 V)
Reading mass flow controller (0-5 V)
Not connected
Not connected
UV detector (0-50 mV)
RI detector (0-50 mV)
Not connected
K type thermocouple for F1
K type thermocouple for F3
K type thermocouple for cold bath
Not connected
Reading F2 temperature controller (4-20 mA)
Not connected
Not connected
Setting F2 temperature comtroller (4-20 mA)
Not connected
Not connected
Setting mass flow controller (0-5 V)
$62
$63
$64
valve SEC-400, control PAC-S5 v2, STEC Japan). These
are used to maintain consistent synthesis and to search
for leaks during the diagnostic check before synthesis.
They are important for maintaining the reliability of the
apparatus.
AC 100 V supply
A series of AC 100 V outlets with safety breakers supply
power to both racks.
Cooling system
The lower half of the supply rack contains the cooling
system, consisting of a ’cool pipe’ cooler with a minimum
temperature of -50C, a circulating micro pump, a
voltage controller and a 3 Dewar tank of coolant
(fluorinert FC77). Solenoid valves are used to stop and
direct the flow of coolant to F1 or F2.
The software was developed to be compatible with
the total automated-labelling production system, in-
cluding the cyclotron and the PET camera. MIASA
reliably completes the link between the production
of the positron emitter radionuclide, 11C, and the
delivery of the lC-labelled radiopharmaceutical for
PET study.
Application to the synthesis of
3-N-[
11C]methylspiperone
Spiperone, 1, and its N-methylated analogue, 2, are
widely used butyrophenone neuroleptics that have been
labelled with short-half life positron emitters, such as
1C (tl/2 =-20"4min) and 18F (tl/2 --109"6min), to
give useful ligands for studying both dopamine and
serotonin receptor binding in vivo I-7, 8-1. The synthesis of
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Figure 13. Set up of the sensors for Controlling HPLC In-
jection. 1 6-way micro-rotary valve for HPLC auto-injection;
2 photosensors; 3 flask # 2.
3-N-[11C]methylspiperOne was used to test the operation
of the system.
F
F
0
N-CH3 N ...,,/
Figure 14. Layout of the Purification Unit. 1 HPLC injection
valve for manual use; 2 6-way micro-rotary valve for HPLC
auto-injection; 3,4--6-way selection valves; 5--HPLC UV
detector; 6 positron detector; 7 HPLC pump.
Experiments
Materials and reagents
Materials and reagents were purchased as follows:
spiperone and 2-N-methylspiperone fromJanssen Pharma-
ceuticals or Funakoshi Pharmaceuticals; Tetrahydrofuran
(THF), lithium aluminium hydride (LAH) powder,
tetrabutylammonium hydroxide 10 aq. (TBAOH),
hydroiodic acid 57 aq., 1,2-dichlorobenzene and di-
chloromethane were from Wako Chemicals Ltd; 1"0 M
solution of LAH/THF was from Aldrich Chemicals Ltd;
sodalime (grade No. 1) was from Kanto Chemicals; and
phosphorus pentoxide from Fluka Chemie AG. Isotonic
saline solution was from Otsuka Pharmaceuticals. The
0"22 l.tm sterilizing filter was from Milex (GV25 for low
adsorption).
Preparation of the apparatus
THF was freshly distilled over lithium aluminium hydride
under argon atmosphere. After refluxing for 2-3 h the
distillate was collected in a trap, and a portion (18 ml)
withdrawn through a rubber septum using a gas-tight
syringe. The THF was injected into a vial (30 ml), capped
with a Teflon-lined septum and flushed with argon.
Addition of 2"0 ml of a commercial 1"0 M LAH/THF
solution gave a 0"1 M solution of LAH/THF that was
stored in a desiccator over P205 and silica gel until use.
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The reservoirs of the apparatus were filled as follows:
Reservoir # (R1)--c. 0"5 ml of HI(aq) (57%).
Reservoir # 2 (R2)--c. 0"5 ml of a spiperone solution in
a 70:30 v/v mixture of 1,2-dichlorobenzene and di-
chloromethane (0"83 x 10-3 M).
Reservoir #3 (R3)--c. 0"5 ml ofTBAOH(aq) (10).
Reservoir # 4 (R4)--c. 0"5 ml of a 56:44 v/v mixture of
M HCI(aq)/THF (0"56 M).
Reservoir #5 (R5)--c. 10ml isotonic saline/ethanol
"(100:5 v/v).
Reservoir #6 (R6)--c. 5 ml Na2CO3(aq) (0"1 M).
The P2Os/sodalime trap was filled and the six-way valve
holding the trap was set to direct the flow through the
trap. The drying tube on the argon line was filled with
2-3 g ofP2Os. The HPLC eluant was prepared by mixing
disodium hydrogen citrate (0"04 M) and methanol in the
ratio 52"5:47"5 v/v, followed by degassing under reduced
pressure and sonication. An authentic sample of 3-N-
methylspiperone in the eluant was manually injected (c.
500 lal; 50 nmol), and the retention time confirmed to be
about 10min using the following chromatographic
conditions: column, Capcell pak SG 120 (15 x 150 mm +
15 x 30mm precolumn); flow rate, 9"5 ml/min; wave-
length, 254 nm.
Diagnostic check of the apparatus
The status of the apparatus was checked to be ready tbr
synthesis, as outlined in figure 5. The position of
the six-way rotary valves was checked and set to the
correct starting position if necessary. Similarly, the
position of the syringe pump was checked and photo-
sensors on the reservoir lines were confirmed to be off.
Leak tests on F1-F4 and the sodalime/P205 trap were
performed by closing all outlets, opening them to the
argon flow line and monitoring the mass flow controller
reading. If zero flow could not be obtained, the source of
the leak was searched for and remedied.
Get ready to start a synthesis
Flask F1 was cooled to about 20C ($63 on) and flushed
with dry argon gas (V5 on) before the LAH/THF solution
(100 gl, 10 gmol LAH) was injected. Cooling was con-
tinued while the target was irradiated for up to 40 min.
Collection of [elc_]carbon dioxide
The contents of the target were swept to the cryotrap and
[11C]carbon dioxide was trapped in a coiled tube dipping
into liquid argon. The start of transfer, SOT, to MIASA
was begun by raising the coil from the liquid argon and
flushing with He gas (10ml/min). The radioisotope
detector on the inlet line was used to monitor the release
of radioactivity from the trap, and valves V9/V9a were
opened to direct the flow to F1 when the peak of 11COz
was detected. The outlet from F1 (V40) was opened to a
sodalime trap to prevent any leakage of radioactive gas.
The peak of radioactivity was collected for 2-3"5 min for
a 20-40 min irradiation of the target (Nz: 14"7 kg/cm2;
15 gA).
During the collection of CO2, spiperone solution was
added to F2. The outlet of F2 was opened by switching
on V29 and measurement from R2 was performed by
opening V12 and V24 until photosensor #2 (PS2)
switched on, and then opening V23 to flush the measured
volume to F2. Addition was repeated three times to add
a total of 300 lal, mg spiperone.
[11CJMethyl iodide synthesis and labelling
After the collection of 1CO2 in F1 the THF was
evaporated by evacuation and heating to 130C for 2 min.
Flask F1 was then cooled to c. 45C by switching on the
cooling pump. Valves V15 and V29 were opened and
HI(aq) solution (1501.tl) was added from R1. This
addition immediately released [11C]methanol which was
then converted to [11C]methyl iodide by reaction with
HI(aq) solution on further heating to 130C. [11C]Methyl
iodide was transferred to F2 under a stream of argon gas
at 10 ml/min, through the sodalime/P2Os trap. Flask F2
was cooled for a short period before transfer, to improve
the trapping efficiency of [lXC]methyl iodide in the
spiperone solution. In order to determine how much
[11C]methyl iodide was not trapped in F2, the outlet gas
was directed (V21 on) into a balloon put inside a Curie
meter.
Transfer from F1 was stopped after 3 min by closing V15,
and TBAOH base (200 gl) was added to F2 from R3.
Flask F2 was completely closed and then heated to 65C,
set with the temperature controller (AOUT1). The HPLC
pump was also started in preparation for the next step.
HPLC injection
After 4 min reaction, the injection of the reaction mixture
into the HPLC column was started. The six-way micro
rotary valve, holding the injection loop, was turned to
the load position and valves V45 and V29 were opened.
The eluant in the loop was pushed by the syringe pump
to fill the Teflon tube between the loop and F2. When
photosensor # 11 (PS11) detected the liquid just above
F2, a short time (3 s) was allowed for the tubing to be
completely filled, and then the push was stopped by
closing V45. The reaction mixture in F2 was neutralized
by addition ofdilute UClaq (1 M)/THF (56:44 v/v) from
R4. Valves V14 and V28 were opened until photosensor
# 4 (PS4) switched on, and then V27 was opened to flush
the measured volume of acid (100 l.tl) to F2. Stirring in
F2 was stopped and the two-phase reaction mixture
allowed to separate. The addition ofTHF with the acid
helped to speed up the separation and reduce the
cloudiness of the mixture, which was essential for the
operation of the photosensors. The reaction mixture in
F2 was loaded into the injection loop by opening V45
and pulling with the syringe pump until photosensor # 6
(PS6) detected that no solution remained in the Teflon
tube. The HPLC six-way valve was then turned to inject.
The heater of F3 was then switched in preparation for
the subsequent evaporation step.
Product collection
The UV and radioisotope detectors on the HPLC line
were monitored and recorded on the computer, and the
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3-N-[11C]methylspiperone peak eluting at c. 10 min was
collected into F3 by opening V16. Nitrogen gas was
bubbled through F3 to start the evaporation of the eluant
as soon as collection proceeded. Collection was stopped
by closing V16, and evaporation was continued under
evacuation. Opening V39 at the same time ensured that
the delivery line into F3 was emptied and also helped to
prevent loss of product by bumping.
In order to determine the radiochemical yield and specific
activity at end of synthesis (EOS), the product could be
collected into a volumetric flask placed in a Curie meter
(runs HR6, HR8 and HR9), and no further formulation
was performed. The collection fraction was made up to
25 ml with HPLC mobile phase after radioactivity had
decayed and the amount of 3-N-methylspiperone was
analyzed by HPLC.
Product formulation
After allowing 9 min for evaporation to dryness in F3, the
heater and vacuum pump were switched off and saline
solution (5 ml) added from R3. The product was dissolved
in the saline by stirring and bubbling nitrogen gas.
Applying the vacuum pump for a short time (2 s)
improved the dissolution of the product by making the
bubbling of nitrogen gas more vigorous, which resulted
in more effective washing of the top part of F3 with the
saline solution.
Flask F4 was emptied of water by opening valves V42,
V33 and switching on the vacuum pump, and then the
saline solution was transferred from F3 for pH adjustment.
Sodium carbonate solution (0"1 M) was added from R6
by repeatedly openingV 19 for s, until the pH was within
the range 7"0 __
1"0. The volume of the final solution in
F4 was adjusted to 10 __
ml (set by the level sensor
position) by adding more saline from R5. Valves V18 and
V38 were opened for s, and then V43 and V37 were
opened to flush saline to F4.
Finally, the product solution was filtered through a
0"22 lam sterile filter into a sealed vial by applying nitrogen
gas pressure. The vial was placed in a Curie meter to
allow the amount of radioactivity in the product to be
measured. The specific activity of the product was
calculated after HPLC analysis ofthe 3-N-methylspiperone
in the final solution at 18 h after end of bombardment
(EOB).
Washing
Washing of the apparatus could be started immediately
after collection of the product. The position of the six-way
valve holding the sodalime/P205 trap was changed to
direct the flow through a bypass and the photosensors on
the reservoir lines were switched off with a relay. F1 and
R1 were washed with water and then the soda lime/P20
trap and F2 were washed by opening V15 and V29 to
pass water from F 1. F2 was also washed from the reservoir
line via each of V23, V25 and V27. Washing was then
repeated with acetone. F3 and F4 were washed with
methanol and water, leaving water in F4 to preserve the
pH meter.
The HPLC column was washed with water (c, 3 min,
9"5 ml/min), 90 methanol (c. 12 min, 9"5 ml/min) and
then water again (c. 3 min, 9"5 ml/min), to remove
dichlorobenzene and prevent build up of impurities.
Results and discussion
The total synthesis time from the end of bombardment
to production of the sterilized saline solution was approxi-
mately 40 min. Table 2 shows the amounts and specific
activities of 3-N-[lXC]methylspiperone produced on
several runs, including runs where the product was
collected before formulation. For a 40 min irradiation
using 18 MeV protons at 15 laA, producing c. Ci of
[11C]CO2, the specific activity was over 1"5 Ci/gmol at
the end of synthesis and c. Ci/gmol at the end of
formulation. The decay corrected radiochemical yield of
the 3-N-[11C]methylspiperone from [11C]COz, in the
injectable solution, was approximately 25. The losses of
Table 2. Results of synthetic runs for 3-N- C_]methylspiperone (NMSP).
Target NMSP at NMSP at RI at RI at Sp. Act.
Run irradiation EOS EOF EOS EOF at EOS
no. min/gA/kgfcm- nmol nmol mCi mCi mCi/I.tmol
Sp. Act.
at EOFf
mCi/lamol
Approx.
RCY
HR6 20/15/14-7 117 149.6 1279
HR8 20/15/14.7 59 71 1203
HR9 40/15/14"7 66 112-5 1705
HR 10 40/15/14.7 85 64 136" 72"9" 1600
HRll 40/15/14-7 82 54 146" 58"3 1800 1080
83
31
31
38
25
a. Calculated from UV detector peak area at separation by HPLC (end of synthesis).
b. Calculated ti’om UV detector peak area on HPLC analysis of formulated product (18 h after end of bombardment).
c. Measured by collecting product from HPLC into a flask placed inside a Ci meter.
d. Measured by collecting product from F4 into a vial placed inside a Ci meter.
e. Calculated specific activity of product collected after HPLC separation.
./ Calculated specific activity of sterile product collected in vial.
g. Estimated decay corrected radiochemical yields based on expected amount of [11C]carbon dioxide produced.
h. 30 min required, as beam current lost for 10 min, c. 450 mCi [11C]CO2 expected.
j. c. 580 mCi [11C]CO2 expected.
k. c. 946 mCi [11C]CO2 expected.
m. Estimated radioactivity from measured values at EOF.
n. Includes radioactivity retained on sterilizing filter.
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radioactivity that were measured (Runs HR10 and
HRll) included 0"5 as [lxC]CO2 and 12o as [xC]-
methyl iodide (decay corrected radiochemical yields).
Thus the synthesis and formulation of 3-N-[lC]methyl
spiperone with the fully automated apparatus MIASA
was sufficiently fast for a high specific activity product
to be obtained, suitable for dopamine and serotonin
receptor binding studies. The specific activity previously
reported by Burns et al. [9], using a similar reaction
condition, was significantly lower (270 mCi/lamol). The
high specific activity is presumably a result of the
precautions taken in the preparation and handling
of [C]methyl iodide-- notably in the preparation
of the LAH/THF solution, the conditioning of the
flow lines and F1 with dry argon gas before synthesis
and the use of high purity (99"9999) nitrogen gas
as the target material.
Improvements were made to the hardware and software
during the development of the apparatus. For example
the use of a mass flow controller, to monitor and regulate
gas flows, aided the detection and elimination of leaks
prior to synthesis runs. Safety and reliability were
improved. The use of three photosensors to control the
injection procedure, improved the reproducibility of this
crucial step.
The computer interface unit (OPTOMUX) and software
are compatible with the total production system of PET
radiopharmaceuticals. In future, it will be possible (using
the present hardware) to use feedback to monitor and
control such processes as solvent evaporation (THF in F1
and temperature maintenance.
3-N-[xC]Methylspiperone was synthesized to show the
performance of the apparatus; MIASA can easily be
adapted to synthesize a variety of [lC]methylated
compounds. The selective dopamine receptor ligand,
[xXC]raclopride, has also been synthesized.
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